Profile

Dr Mingming Xu received his PhD degree from Griffith University, Australia. Before joining Xi’an Jiaotong-Liverpool University, he did postdoctoral research at Soochow University for over two years. His previous researches include development of fluorescent probes for the diagnosis of Alzheimer’s disease, mass spectrometry-based discovery of small molecule inhibitors against alpha-synuclein aggregation, and discovery of biomarkers for Parkinson’s disease and pancreatic cancer via glycoproteomics.

Dr Xu's current research interests focus on mass spectrometry-based discovery of clinical biomarkers for common neurodegenerative diseases, identification of exosomal biomarkers from biofluids for human common cancers, and understanding the pathogenesis of Parkinson’s disease.